{Reference Type}: Letter
{Title}: Commentary on "Mesothelin CAR-T cells expressing tumor-targeted immunocytokine IL-12 yield durable efficacy and fewer side effects".
{Author}: Wang Y;Zhao G;Xing S;Wang S;Li N;
{Journal}: Pharmacol Res
{Volume}: 206
{Issue}: 0
{Year}: 2024 Aug 24
{Factor}: 10.334
{DOI}: 10.1016/j.phrs.2024.107267